|
History and Overview
The Biomedical Engineering program at Rutgers University was initially established in 1965 as a track within electrical engineering, offering M.S. degrees with a biomedical engineering emphasis. In 1986, the State of New Jersey formally chartered the Rutgers Department of Biomedical Engineering as an independent entity within the School of Engineering with exclusive responsibility for granting M.S. and Ph.D. degrees in biomedical engineering. The Department developed its graduate programs in collaboration with the University of Medicine and Dentistry of New Jersey (UMDNJ) to provide a strong foundation in the basic biomedical and clinical sciences along with rigorous training in engineering fundamentals. The undergraduate program in biomedical engineering was inaugurated in 1991 under the “applied sciences” option within the School of Engineering; a formal undergraduate BS degree in BME was approved by the University in 1997 and by the State in 1999.
The graduate program in biomedical engineering, which is jointly administered by Rutgers and UMDNJ, has grown remarkably, and currently hosts over 80 faculty from the Rutgers science and engineering departments and UMDNJ's basic biomedical science and clinical science departments.
The primary educational mission of the department is to provide outstanding BS, MS, and PhD level training in the following critical areas of biomedical engineering and technology:
- Molecular, Cellular, and Nanosystems Bioengineering
- Biomaterials and Tissue Engineering
- Biomechanics and Rehabilitation Engineering
- Physiologic Systems and Bioinstrumentation
- Computational Bioengineering and Biomedical Imaging
As of July 1, 2005, the department census was as follows:
- 27 core departmental faculty
- 82 graduate program faculty
- 6 educational and research staff members
- 231 BS students
- 33 MS students
- 65 PhD students
Faculty within the Department of Biomedical Engineering hold prominent positions in the following university-wide “Centers-of-Excellence”:
|
|
|
|
Contribute
|
|
Contribute to Biomedical Engineering at Rutgers.Click here for more information.
|
|
Latest News |
Li Cai Awarded Busch Biomedical Research Grant
July 01, 2008
Li Cai received a two year $50,000 Busch Biomedical Research Grant to support his research on "Control of CD44 Expression in Breast Cancer Stem Cells". The project is to study the transcription regulation of breast cancer stem cells.
Annual Review of Biomedical Engineering Ranked No. 1 again by ISI
June 23, 2008
For the sixth year in a row, articles in the Annual Review of Biomedical Engineering (ARBME) were cited more often than papers in any of its peer journals, according to ISI's 2007 Journal Citation Report, giving it the highest "impact factor" in its peer group. The ARBME had an impact factor of 11.567 placing it #1 in its peer group of 44 journals, and #2 among all engineering journals. Professor Martin Yarmush serves as the editor-in-chief of the ARBME which published its first volume in 1999.
John Semmlow awarded $750,000 NIH-NIHLB Grant
June 13, 2008
John Semmlow and SonoMedica, Inc. of McClean, VA were awarded a Phase II STTR grant of $750,000 from the NIH-NIHLB over two years to advance his work on detection of coronary artery disease using acoustic information.
Anant Madabhushi awarded $260,000 Wallace H. Coulter Grant
June 11, 2008
Anant Madabhushi has been awarded a 2 year Phase 2 grant for $260,000 from the Wallace H. Coulter foundation for his proposal entitled "Automated Detection of Prostate Cancer from Multi-protocol High Resolution MRI". The Phase 2 award was competitive and of the 25 Phase 1 Early Career awardees only 7 were selected for Phase 2 based on progress made in Phase 1, a new grant application, and an oral presentation in front of a review committee in Florida, in early June. Under the Phase 2 project, Dr. Madabhushi will look to commercialize his ongoing research in developing computerized detection methods for prostate cancer using MRI. Clinical collaborators on this project are Dr. John Tomaszewski, Dr. Mark Rosen, and Dr. Mike Feldman from the University of Pennsylvania.
More News >>
|
|
|